Omnicell, Inc.

OMCL Healthcare Health Information Services

Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.

35.39 0.56 −1.56%
Market cap
$1.6B
P/E
41.6×
Fwd P/E
55.1×
Dividend yield
—
F-score
7/9
Altman Z
2.69
Beneish M
−2.85
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
659.62 680.07 722.30 735.39
Total non-current assets
1,288.98 1,294.65 1,281.80 1,263.47
Total Assets
1,948.60 1,974.72 2,004.11 1,998.86
Total current liabilities
456.59 476.61 483.05 447.44
Total non-current liabilities
271.11 266.30 264.43 259.81
Total liabilities
727.70 742.91 747.48 707.25
Common Equity (Total)
1,220.90 1,231.81 1,256.63 1,291.61
Shareholders Equity (Total)
1,220.90 1,231.81 1,256.63 1,291.61
Total Debt
167.29 167.60 167.90 168.20

Show all line items

In millions of $ except per-share values · columns are period end dates